Publication Name	World Journal of Nephrology
Manuscript ID	37366
Country	Australia

Received	2017-12-18 08:52
Peer-Review Started	2017-12-18 09:34
To Make the First Decision	2018-01-23 03:21
Return for Revision	2018-01-23 09:24
Revised	2018-01-29 07:22
Second Decision	2018-02-08 11:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-02-28 17:27
Articles in Press	2018-02-28 17:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-03-05 03:42
Publish the Manuscript Online	2018-03-06 01:54

ISSN	2220-6124 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Clinical Neurology
Manuscript Type	Review
Article Title	Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
Manuscript Source	Unsolicited Manuscript
All Author List	Moomal Tasneem, Carly Mannix, Annette Wong, Jennifer Zhang and Gopala Rangan
ORCID	Author(s) ORCID Number Moomal Tasneem http://orcid.org/0000-0001-5636-4602 Carly Mannix http://orcid.org/0000-0001-5518-9099 Annette Wong http://orcid.org/0000-0002-0919-330X Jennifer Zhang http://orcid.org/0000-0003-3269-3801 Gopala Rangan http://orcid.org/0000-0002-2147-0998
Funding Agency and Grant Number
Corresponding Author	Gopala Rangan, FRACP, MBBS, PhD, Associate Professor, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, the University of Sydney, 176 Hawkesbury Road, Westmead, Sydney 2145, Australia. g.rangan@sydney.edu.au
Key Words	Polycystic kidney disease; Copeptin; Biomarker
Core Tip	Serum copeptin is correlated with disease severity in autosomal dominant polycystic kidney disease (ADPKD), and predicts future renal events (decline in renal function and increase in total kidney volume). The aim of this review is to critically evaluate the role of copeptin as a prognostic biomarker of renal outcomes in ADPKD, and if it has potential as a predictive marker of treatment response.
Publish Date	2018-03-06 01:54
Citation	Tasneem M, Mannix C, Wong A, Zhang J, Rangan G. Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease? World J Nephrol 2018; 7(2): 51-57
URL	http://www.wjgnet.com/2220-6124/full/v7/i2/51.htm
DOI	http://dx.doi.org/10.5527/wjn.v7.i2.51

Full Article (PDF)	WJN-7-51.pdf
Full Article (Word)	WJN-7-51.doc
Manuscript File	37366-Review.docx
Answering Reviewers	37366-Answering reviewers.pdf
Audio Core Tip	37366-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	37366-Conflict-of-interest statement.pdf
Copyright License Agreement	37366-Copyright assignment.pdf
Peer-review Report	37366-Peer-review(s).pdf
Scientific Misconduct Check	37366-Scientific misconduct check.pdf
Scientific Editor Work List	37366-Scientific editor work list.pdf